GLP-1 (Semaglutide) vs. AOD-9604: Cognitive Comparison

For cognitive optimization, GLP-1 (Semaglutide) and AOD-9604 serve different neurological functions. GLP-1 (Semaglutide) is primarily indicated for significant weight loss via appetite suppression and metabolic improvement., while AOD-9604 excels at targeted fat metabolism and body composition improvement without gh-related side effects.. The choice depends on the specific cognitive goal — focus enhancement, anxiety reduction, neuroprotection, or sleep quality improvement.

CNS delivery route is a critical consideration: intranasal administration bypasses the blood-brain barrier via the olfactory nerve, providing faster and more direct CNS access than subcutaneous injection. For both compounds, physician supervision and regular cognitive assessments are recommended to optimize protocols.